참고문헌
- Arias E. (2014). United states life tables, 2009. Natl Vital Stat Rep, 62, 1-63.
- Bedenne L, Michel P, Bouche O, et al (2007). Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol, 25, 1160-8. https://doi.org/10.1200/JCO.2005.04.7118
- Chen Z, Chen Q, Xia H, Lin J (2011). Green tea drinking habits and esophageal cancer in southern China: a case-control study. Asian Pac J Cancer Prev, 12, 229-33.
- D'Journo XB, Thomas PA (2014). Current management of esophageal cancer. J Thorac Dis, 6, 253-64.
- Hironaka S, Ohtsu A, Boku N, et al (2003). Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T (2-3)N (any) M (0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys, 57, 425-33. https://doi.org/10.1016/S0360-3016(03)00585-6
- Igissinov N, Tereshkevich D, Moore MA, et al (2011). Age characteristics of incidences of prevalent cancers in the Aral Sea area of Kazakhstan. Asian Pac J Cancer Prev, 12, 2295-7.
- Kawashima M, Ikeda H, Yorozu A, et al. (1998). Clinical features of esophageal cancer in the octogenarian treated by definitive radiotherapy: a multi-institutional retrospective survey. Jpn J Clin Oncol, 28, 301-7. https://doi.org/10.1093/jjco/28.5.301
- Li G, Hu W, Wang J, et al (2010). Phase II study of concurrent chemoradiation in combination with erlotinib for locally advanced esophageal carcinoma. Int J Radiat Oncol Biol Phys, 78, 1407-12. https://doi.org/10.1016/j.ijrobp.2009.10.012
- Liu SZ, Wang B, Zhang F, et al (2013). Incidence, survival and prevalence of esophageal and gastric cancer in Linzhou city from 2003 to 2009. Asian Pac J Cancer Prev, 14, 6031-4. https://doi.org/10.7314/APJCP.2013.14.10.6031
- Minsky BD, Pajak TF, Ginsberg RJ, et al (2002). INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol, 20, 1167-74. https://doi.org/10.1200/JCO.20.5.1167
- Mirinezhad SK, Somi MH, Seyednezhad F, et al (2013). Survival in patients treated with definitive chemoradiotherapy for non-metastatic esophageal cancer in north- west iran. Asian Pac J Cancer Prev, 14, 1677-80. https://doi.org/10.7314/APJCP.2013.14.3.1677
- Mirinezhad SK, Somi MH, Shirmohamadi M, et al (2013). Impact of postoperative chemoradiotherapy and chemoradiotherapy alone for esophageal cancer in North-West Iran. Asian Pac J Cancer Prev, 14, 3921-4. https://doi.org/10.7314/APJCP.2013.14.6.3921
- Mountain CF, Dresler CM (1997). Regional lymph node classification for lung cancer staging. Chest, 111, 1718-23. https://doi.org/10.1378/chest.111.6.1718
- Nallapareddy S, Wilding GE, Yang G, Iyer R, Javle M (2005). Chemoradiation is a tolerable therapy for older adults with esophageal cancer. Anticancer Res, 25, 3055-60.
- Rochigneux P, Resbeut M, Rousseau F, et al (2014). Radio (chemo) therapy in elderly patients with esophageal cancer: a feasible treatment with an outcome consistent with younger patients. Front Oncol, 4, 100.
- Shen K, Huang XE, Lu YY, Wu XY, Liu J, Xiang J (2012). Phase II study of docetaxel (Aisu (R)) combined with three- dimensional conformal external beam radiotherapy in treating patients with inoperable esophageal cancer. Asian Pac J Cancer Prev, 13, 6523-6. https://doi.org/10.7314/APJCP.2012.13.12.6523
- Stahl M, Walz M K, Stuschke M, et al (2009). Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol, 27, 851-6. https://doi.org/10.1200/JCO.2008.17.0506
- Suh YG, Lee IJ, Koom WS, et al (2014). High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer. Jpn J Clin Oncol, 44, 534-40. https://doi.org/10.1093/jjco/hyu047
- Tougeron D, Di Fiore F, Thureau S, et al (2008). Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer, 99, 1586-92. https://doi.org/10.1038/sj.bjc.6604749
- Uno T, Isobe K, Kawakami H, et al (2004). Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer. Anticancer Res, 24, 2483-6.
- Xu H Y, ZD, Zhou L, et al (2014). Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma. Oncol Lett, 7, 260-6. https://doi.org/10.3892/ol.2013.1694
- Yuan P, Chen TH, Chen ZW, Lin XQ. (2014). Calculation of life-time death probability due malignant tumors based on a sampling survey area in China. Asian Pac J Cancer Prev, 15, 4307-9. https://doi.org/10.7314/APJCP.2014.15.10.4307
- Zhang Y. (2013). Epidemiology of esophageal cancer. World J Gastroenterol, 19, 5598-606. https://doi.org/10.3748/wjg.v19.i34.5598
피인용 문헌
- Feasibility of Elective Nodal Irradiation (ENI) and Involved Field Irradiation (IFI) in Radiotherapy for the Elderly Patients (Aged ≥ 70 Years) with Esophageal Squamous Cell Cancer: A Retrospective Analysis from a Single Institute vol.10, pp.12, 2015, https://doi.org/10.1371/journal.pone.0143007
- Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy vol.95, pp.50, 2016, https://doi.org/10.1097/MD.0000000000005630
- Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer vol.41, pp.9, 2018, https://doi.org/10.1097/COC.0000000000000390
- Aging-related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer vol.7, pp.5, 2018, https://doi.org/10.1002/cam4.1456
- Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis vol.13, pp.1, 2018, https://doi.org/10.1186/s13014-018-1044-8
- ) and DWI Apparent Diffusion Coefficient as Predictive Markers of Short- and Long-Term Efficacy of Chemoradiotherapy in Patients With Esophageal Cancer vol.17, pp.1533-0338, 2018, https://doi.org/10.1177/1533034618765254
- Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers vol.8, pp.1, 2019, https://doi.org/10.1002/cam4.1788